Real-World Cost-Effectiveness Analysis of Gemcitabine and Cisplatin Compared to Docetaxel and Cisplatin Plus Fluorouracil Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma

BACKGROUND: Addition of gemcitabine and cisplatin (GP) or docetaxel and cisplatin plus fluorouracil (TPF) to concurrent chemoradiotherapy (CCRT) significantly improved survival in locoregionally advanced nasopharyngeal carcinoma (NPC). However, an economic evaluation of these regimens remains unknown...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Front Oncol
Главные авторы: Yang, Jiangping, Han, Jiaqi, He, Jinlan, Duan, Baofeng, Gou, Qiheng, Ai, Ping, Liu, Lei, Li, Yanchu, Ren, Kexing, Wang, Feng, Yao, Min, Chen, Nianyong
Формат: Artigo
Язык:Inglês
Опубликовано: Frontiers Media S.A. 2020
Предметы:
Oncology
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7786365/
https://ncbi.nlm.nih.gov/pubmed/33425747
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.594756
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы